$RFIL Cashflow Statement | Understand Stock

$RFIL

$7.68 +$0.32 (4.35%) Close

$RFIL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Oct 31, 2025	FY2024 12 months to Oct 31, 2024	FY2023 12 months to Oct 31, 2023	FY2022 12 months to Oct 31, 2022	FY2021 12 months to Oct 31, 2021
OPERATING ACTIVITIES:
Consolidated net income (loss)
Adjustments to reconcile consolidated net income (loss) to net cash provided by operating activities:
Bad debt expense
Depreciation and amortization
Gain on disposal of fixed assets
Stock-based compensation expense
Amortization of debt issuance cost
Tax payments related to shares cancelled for vested restricted stock awards
Deferred income taxes
Extinguishment of debt issuance cost
Changes in operating assets and liabilities:
Trade accounts receivable
Inventories
Other current assets
Right-of-use assets
Other long-term assets
Accounts payable
Accrued expenses
Income taxes payable
Other long-term liabilities
Net cash provided by operating activities

INVESTING ACTIVITIES:
Proceeds from sale of fixed assets
Capital expenditures
Purchase of Microlab, net of cash acquired ($33)
Schrofftech
Total purchase of Microlab, net of cash acquired ($33)

Net cash used in investing activities
FINANCING ACTIVITIES:
Proceeds from exercise of stock options
Dividends paid
Debt issuance cost
Line of credit payments
Line of credit draws
Term Loan payments
Term Loan
Net cash used in financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental cash flow information – income taxes paid
Supplemental cash flow information – interest paid

Comments